Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.007 | 0.9 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |